APA (7th ed.) Citation

Ogasawara, K., MacGorman, K., Liu, L., Chen, J., Carayannopoulos, L. N., Zhou, S., . . . Li, Y. (2019). Drug‐Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC‐122) in Healthy Adult Subjects. Journal of clinical pharmacology, 59(12), 1620-1631. https://doi.org/10.1002/jcph.1453

Chicago Style (17th ed.) Citation

Ogasawara, Ken, Kimberly MacGorman, Liangang Liu, Jian Chen, Leonidas N. Carayannopoulos, Simon Zhou, Maria Palmisano, and Yan Li. "Drug‐Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC‐122) in Healthy Adult Subjects." Journal of Clinical Pharmacology 59, no. 12 (2019): 1620-1631. https://doi.org/10.1002/jcph.1453.

MLA (9th ed.) Citation

Ogasawara, Ken, et al. "Drug‐Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC‐122) in Healthy Adult Subjects." Journal of Clinical Pharmacology, vol. 59, no. 12, 2019, pp. 1620-1631, https://doi.org/10.1002/jcph.1453.